| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |